GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixxer Ltd (FRA:2LQ) » Definitions » EV-to-Revenue

Elixxer (FRA:2LQ) EV-to-Revenue : 122.09 (As of May. 24, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Elixxer EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Elixxer's enterprise value is €6.96 Mil. Elixxer's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was €0.06 Mil. Therefore, Elixxer's EV-to-Revenue for today is 122.09.

The historical rank and industry rank for Elixxer's EV-to-Revenue or its related term are showing as below:

FRA:2LQ' s EV-to-Revenue Range Over the Past 10 Years
Min: -2466.69   Med: 247.32   Max: 170302
Current: 111.74

During the past 13 years, the highest EV-to-Revenue of Elixxer was 170302.00. The lowest was -2466.69. And the median was 247.32.

FRA:2LQ's EV-to-Revenue is ranked worse than
96.78% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.3 vs FRA:2LQ: 111.74

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-24), Elixxer's stock price is €0.814. Elixxer's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was €0.01. Therefore, Elixxer's PS Ratio for today is 162.80.


Elixxer EV-to-Revenue Historical Data

The historical data trend for Elixxer's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elixxer EV-to-Revenue Chart

Elixxer Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Sep17 Sep18 Dec20 Dec21 Dec22
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 372.34 1,280.79 229.72 226.72

Elixxer Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 396.04 226.72 247.31 259.02 267.33

Competitive Comparison of Elixxer's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Elixxer's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elixxer's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elixxer's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Elixxer's EV-to-Revenue falls into.



Elixxer EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Elixxer's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=6.959/0.057
=122.09

Elixxer's current Enterprise Value is €6.96 Mil.
Elixxer's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elixxer  (FRA:2LQ) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Elixxer's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.814/0.005
=162.80

Elixxer's share price for today is €0.814.
Elixxer's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elixxer EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Elixxer's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Elixxer (FRA:2LQ) Business Description

Traded in Other Exchanges
Address
1100 Boulevard Rene- Levesque Ouest, Suite 700, Montreal, QC, CAN, H5B 4N4
Elixxer Ltd is a Canada-based cannabis investment firm in the legal cannabis market. It invests in cannabis-related businesses that are fully licensed for the cultivation, production, and sale of cannabis and cannabis-derived products.

Elixxer (FRA:2LQ) Headlines

No Headlines